Pancreatic Cancer Research

ResearcherGuiyang Medical UniversityActive in the last 2 years

Tengxiang Chen

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-6907-1374; OpenAlex author ID A5036459692, A5039207104. Sources: OpenAlex.

Their work

Papers
9 (first author 0, last author 4)
Trials
0
Grants
0
Labs led
1
Collaborators
15
Papers, trials and grants by year

2019: 1 paper · 2020: 1 paper · 2021: 1 paper · 2022: 1 paper · 2023: none · 2024: 3 papers · 2025: 2 papers

Papers 9

  1. aGenome-scale activation screen reveals lncRNA HNF1A-AS1 promotes pancreatic cancer metastasis through interacting with U2SURP to increase CD44 alternative spl… Last author DOI 10.1007/s00535-025-02272-6↗
  2. Development of [18F]AlF-RESCA-H006 as a Novel Molecular Probe for 5T4 Tumor Imaging and Exploration of Its Application in Pancreatic Adenocarcinoma. Co-author DOI 10.1021/acs.molpharmaceut.5c00430↗
  3. Precise Photodynamic Therapy by Midkine Nanobody-Engineered Nanoparticles Remodels the Microenvironment of Pancreatic Ductal Adenocarcinoma and Potentiates the… Co-author DOI 10.1021/acsnano.3c07002↗
  4. Schizandrin A suppressed pancreatic cancer proliferation and cancer associated fibroblast activation via inhibiting the COX-2/ALOX5 shunting Last author DOI 10.1101/2024.10.09.24315180↗
  5. Genome-scale activation screen reveals lncRNA HNF1A-AS1 as a novel therapeutic target for pancreatic cancer metastasis Last author DOI 10.21203/rs.3.rs-5388928/v1↗
  6. Sinapine Thiocyanate Inhibits the Proliferation and Mobility of Pancreatic Cancer Cells by Up-Regulating GADD45A. Last author DOI 10.7150/jca.65212↗
  7. YEATS2 is a target of HIF1α and promotes pancreatic cancer cell proliferation and migration. Co-author DOI 10.1002/jcp.29995↗
  8. Linc00261 inhibits metastasis and the WNT signaling pathway of pancreatic cancer by regulating a miR‑552‑5p/FOXO3 axis. Co-author DOI 10.3892/or.2020.7480↗
  9. Long noncoding RNA 00976 promotes pancreatic cancer progression through OTUD7B by sponging miR-137 involving EGFR/MAPK pathway. Co-author DOI 10.1186/s13046-019-1388-4↗

Closest collaborators

The 15 strongest of 15 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Zhirui Zeng · 7 shared papers, 2019–2025 · strength 1.22
  2. Shan Lei · 7 shared papers, 2019–2025 · strength 1.22
  3. Wenpeng Cao · 2 shared papers, 2024–2025 · strength 0.45
  4. Junbin Han · 2 shared papers, 2022–2025 · strength 0.43
  5. Jinping Kong · 1 shared paper, 2025 · strength 0.28
  6. Zhiwei He · 2 shared papers, 2019–2021 · strength 0.28
  7. Jianxin Jiang · 2 shared papers, 2019–2021 · strength 0.28
  8. Zhiyong Yang · 1 shared paper, 2024 · strength 0.18
  9. Peng Xia · 1 shared paper, 2024 · strength 0.18
  10. Chengming Qu · 1 shared paper, 2024 · strength 0.18
  11. Ming Tian · 1 shared paper, 2024 · strength 0.18
  12. Yufeng Yuan · 1 shared paper, 2024 · strength 0.18
  13. Jingya Wang · 1 shared paper, 2022 · strength 0.15
  14. Bing Guo · 1 shared paper, 2020 · strength 0.11
  15. Xingjun Guo · 1 shared paper, 2019 · strength 0.11

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.